The study showed that gastric cancer mesenchymal stem cells (GCMSCs) can inhibit NK cell function by upregulating the expression of FBP1 in NK cells and decreasing glucose metabolism in NK cells [10]; similarly in lung cancer, FBP1 impairs NK cell viability by inhibiting glycolysis in NK cells [34]. This evidence concerns the gene FBP1 and lung carcinoma.